Study to Evaluate effect of Trivruttadi Ghana Vati in the management of Uttana Vatarakta (Gout).

Evaluation of Efficacy of Trivruttadi Ghana Vati in Uttana Vatarakta (Gout): A Single Arm Clinical Study. - NIL

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2026/01/101965

Enrollment

Registered

2026-01-23

Start date

Unknown

Completion date

Unknown

Last updated

2026-02-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M109- Gout, unspecified

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: Patients showing symptoms of Uttana Vatarakta such as Sandhishoola with shoth sankoch sparshasahtva daha local colour changes in the skin Serum Uric acid level from 4 to 12 mg per dl

Exclusion criteria

Exclusion criteria: Patients with other systemic disorders like Cardiac disease and Renal failure Pregnant women and lactating mothers Injury requiring surgical interventions Any condition interfering the course of treatment

Design outcomes

Primary

Measure	Time frame
Reduction in sign and symptoms of Uttana Vatarakta.Timepoint: 2 Weeks and 4 Weeks	—

Secondary

Measure	Time frame
Reduction of score in Numerical rating scale and Uric acid levels after treatment.Timepoint: 2 Weeks and 4 Weeks	—

Countries

India

Contacts

Public ContactDr Apurva Purushottam Ubhe

Dr. D.Y. Patil College of Ayurveda and Research Centre

lagadabhilasha@gmail.com9284017168

Outcome results